[REVISION HISTORY]

Global medicinal cannabis market expansion

Updated 1 time since CLSTR started tracking revisions of this situation.

What changed

2026-09-01 14:56 UTC → 2026-09-19 14:37 UTC · added ~~removed~~

Global medicinal cannabis markets are experiencing growth and regulatory shifts across several regions. In Portugal, medicinal cannabis exports have ~~risen, exceeding 66~~ seen massive growth. Official reports from Infarmed show that the country exported nearly 80 tonnes in 2025, representing a 156% increase from the ~~first half of~~ previous year and eight times the ~~year, with~~ volume recorded in 2022. By 2024, Portugal was ranked as the ~~European Union—specifically Germany, Spain,~~ second-largest exporter of medicinal cannabis globally, trailing only Canada. Despite this industrial expansion, observers note a lack of serious economic debate regarding the regulation and ~~Denmark—acting as~~ domestic management of the ~~primary market.~~ industry. To manage ~~this volume, the regulatory body~~ high volumes, Infarmed has strengthened inspections and control procedures. Australia has seen record imports, totaling over 81 tonnes in 2025, with Thailand emerging as a significant source alongside Canada, South Africa, New Zealand, and Colombia. While domestic production exceeded 55 tonnes, total available supply reached over 136 tonnes. In Brazil, the market is expanding with 55 active sanitary authorizations held by 25 companies. Data from ANVISA indicates a 29% increase in import authorizations in 2026, driven by patient demand ~~and medical focus on~~ for treating conditions such as refractory epilepsy and chronic neuropathic pain. The industry is approaching a renewal cycle, with ten authorizations scheduled to expire between late 2026 and mid-2027.

Versions

Only revisions since CLSTR began indexing content versions appear here. Select a version to see what changed compared to the one before it.